ACTINIUM PHARMACEUTICALS, INC. Notes Payable, Current
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Notes Payable, Current of $7.51 million as of 2024-03-31, per its 10-Q filed 2024-04-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2024-04-26
- 2024-03-31: Notes Payable, Current $7.51M.
- 2023-12-31: Notes Payable, Current $7.95M.
- 2023-09-30: Notes Payable, Current $8.15M.
- 2023-06-30: Notes Payable, Current $8.64M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2024-03-31 | $7.51M 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $7.95M 10-Q · filed 2024-04-26 | |
| 2023-09-30 | $8.15M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.64M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.36M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $10.13M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $7.87M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.77M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.26M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $5.54M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.77M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.43M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $3.73M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $4.34M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $38.00K 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $154.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $268.00K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $381.00K 10-K · filed 2021-03-31 | $380.55K 10-K · filed 2020-05-08 |
| 2019-09-30 | $25.33K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $100.78K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $175.41K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $249.24K 10-K · filed 2020-05-08 | |
| 2016-06-30 | $89.57K 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $178.12K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $265.69K 10-K · filed 2017-03-16 | |
| 2015-06-30 | $92.27K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $189.76K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $283.55K 10-K · filed 2016-03-11 | |
| 2014-06-30 | $54.97K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $94.48K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $157.82K 10-K · filed 2015-03-16 | |
| 2013-06-30 | $36.95K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $74.67K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $140.00K 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |